ClinicalTrials.gov
ClinicalTrials.gov Menu

Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C (MBL-HCV1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01532908
Recruitment Status : Terminated (The study was terminated due to funding constraints)
First Posted : February 15, 2012
Last Update Posted : April 25, 2017
Sponsor:
Information provided by (Responsible Party):
MassBiologics